ImmunityBio has surged over 200% YTD, yet I see little fundamental justification for its current $10B enterprise value. Click here to read why IBRX is a Sell.

Discover why Kotlin Multiplatform is becoming a game-changer for startup teams. Learn how it reduces development costs, speeds up product launches, and enables seamless cross-platform app ...

Seagate transitioned from a cyclical PC stock to a structurally scarce asset, underpinned by AI-driven data center storage demand. Read why STX is a Strong Buy.

While the company hasn't confirmed its plans, public documents indicate more than 1,400 jobs could be created and tens of millions of dollars could be invested.

Tech shares bounced on Tuesday following the prior session's selloff as markets weigh the impact of artificial intelligence on incumbent technology companies while navigating tariff uncertainty.